Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · November 17, 2011

Mechanisms of Immune Activation of Lenalidomide in B-CLL

British Journal of Haematology

 

Additional Info

British Journal of Haematology
Biological Effects and Clinical Significance of Lenalidomide-Induced Tumour Flare Reaction in Patients With Chronic Lymphocytic Leukaemia: In Vivo Evidence of Immune Activation and Antitumour Response
Br. J. Haematol 2011 Nov 01;155(4)457-467, AA Chanan-Khan, K Chitta, N Ersing, N Bangia, et al

Further Reading